Literature DB >> 19829737

Tissue engineering in urology.

Derek J Matoka1, Earl Y Cheng.   

Abstract

Tissue engineering encompasses a multidisciplinary approach geared toward the development of biological substitutes designed to restore and maintain normal function in diseased or injured tissues. This article reviews the basic technology that is used to generate implantable tissue-engineered grafts in vitro that will exhibit characteristics in vivo consistent with the physiology and function of the equivalent healthy tissue. We also examine the current trends in tissue engineering designed to tailor scaffold construction, promote angiogenesis and identify an optimal seeded cell source. Finally, we describe several currently applied therapeutic modalities that use a tissue-engineered construct. While notable progress has clearly been demonstrated in this emerging field, these efforts have not yet translated into widespread clinical applicability. With continued development and innovation, there is optimism that the tremendous potential of this field will be realized.

Year:  2009        PMID: 19829737      PMCID: PMC2758503          DOI: 10.5489/cuaj.1155

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  43 in total

1.  Regeneration of the urinary bladder in the dog, following total cystectomy.

Authors:  A W BOHNE; R W OSBORN; P J HETTLE
Journal:  Surg Gynecol Obstet       Date:  1955-03

2.  Characterization of small intestinal submucosa regenerated canine detrusor: assessment of reinnervation, in vitro compliance and contractility.

Authors:  B P Kropp; B D Sawyer; H E Shannon; M K Rippy; S F Badylak; M C Adams; M A Keating; R C Rink; K B Thor
Journal:  J Urol       Date:  1996-08       Impact factor: 7.450

3.  Functional rat bladder regeneration through xenotransplantation of the bladder acellular matrix graft.

Authors:  H J Piechota; S E Dahms; M Probst; C A Gleason; L S Nunes; R Dahiya; T F Lue; E A Tanagho
Journal:  Br J Urol       Date:  1998-04

4.  AP-1 mediates stretch-induced expression of HB-EGF in bladder smooth muscle cells.

Authors:  J M Park; R M Adam; C A Peters; P D Guthrie; Z Sun; M Klagsbrun; M R Freeman
Journal:  Am J Physiol       Date:  1999-08

5.  De novo reconstitution of a functional mammalian urinary bladder by tissue engineering.

Authors:  F Oberpenning; J Meng; J J Yoo; A Atala
Journal:  Nat Biotechnol       Date:  1999-02       Impact factor: 54.908

6.  Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder.

Authors:  M R Freeman; J J Yoo; G Raab; S Soker; R M Adam; F X Schneck; A A Renshaw; M Klagsbrun; A Atala
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

7.  Bladder augmentation using allogenic bladder submucosa seeded with cells.

Authors:  J J Yoo; J Meng; F Oberpenning; A Atala
Journal:  Urology       Date:  1998-02       Impact factor: 2.649

8.  Reproduction of functional smooth muscle tissue and partial bladder replacement.

Authors:  M Probst; R Dahiya; S Carrier; E A Tanagho
Journal:  Br J Urol       Date:  1997-04

9.  Experimental assessment of small intestinal submucosa as a bladder wall substitute.

Authors:  B P Kropp; B L Eppley; C D Prevel; M K Rippy; R C Harruff; S F Badylak; M C Adams; R C Rink; M A Keating
Journal:  Urology       Date:  1995-09       Impact factor: 2.649

10.  Regenerative urinary bladder augmentation using small intestinal submucosa: urodynamic and histopathologic assessment in long-term canine bladder augmentations.

Authors:  B P Kropp; M K Rippy; S F Badylak; M C Adams; M A Keating; R C Rink; K B Thor
Journal:  J Urol       Date:  1996-06       Impact factor: 7.450

View more
  8 in total

1.  Autologous urothelial cells transplantation onto a prefabricated capsular stent for tissue engineered ureteral reconstruction.

Authors:  Yongde Xu; Weijun Fu; Gang Li; Jianguo Shi; Haisong Tan; Kun Hu; Fuzhai Cui; Qiuxia Lin; Xu Zhang
Journal:  J Mater Sci Mater Med       Date:  2012-03-02       Impact factor: 3.896

Review 2.  Update on tissue engineering in pediatric urology.

Authors:  Blake W Palmer; Bradley P Kropp
Journal:  Curr Urol Rep       Date:  2013-08       Impact factor: 3.092

3.  Bladder reconstruction: The past, present and future.

Authors:  Omar M S El-Taji; Altaf Q Khattak; Syed A Hussain
Journal:  Oncol Lett       Date:  2015-04-28       Impact factor: 2.967

Review 4.  Therapeutic strategies for patients with micropenis or penile dysmorphic disorder.

Authors:  Oliver Kayes; Majid Shabbir; David Ralph; Suks Minhas
Journal:  Nat Rev Urol       Date:  2012-08-14       Impact factor: 14.432

5.  Future Research Directions in the Design of Versatile Extracellular Matrix in Tissue Engineering.

Authors:  Agustina Setiawati; Huong Thanh Nguyen; Yeongheon Jung; Kwanwoo Shin
Journal:  Int Neurourol J       Date:  2018-07-31       Impact factor: 2.835

Review 6.  Tissue Engineering and Stem Cell Therapy in Pediatric Urology.

Authors:  Shilpa Sharma; Devendra K Gupta
Journal:  J Indian Assoc Pediatr Surg       Date:  2019 Oct-Dec

Review 7.  The evolution of bladder augmentation: from creating a reservoir to reconstituting an organ.

Authors:  Roman Jednak
Journal:  Front Pediatr       Date:  2014-02-10       Impact factor: 3.418

Review 8.  Bioengineered Scaffolds as Substitutes for Grafts for Urethra Reconstruction.

Authors:  Martina Culenova; Dusan Bakos; Stanislav Ziaran; Simona Bodnarova; Ivan Varga; Lubos Danisovic
Journal:  Materials (Basel)       Date:  2019-10-22       Impact factor: 3.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.